Br J Pharmacol 174(7):580590
For patients with an A1C of 6.5% to 7.5%, metformin is the preferred initial agent, with GLP-1 receptor agonists, dipeptidyl-peptidase-4 (DPP-4) inhibitors, thiazolidinediones (TZDs), or an alpha-glucosidase inhibitor listed as viable alternatives
Theres no way to tell ahead of time what your particular experience will be, but you can be ready by both talking to your doctor about potential side effects and gathering advice and information that can help
With forthcoming regulatory decisions and innovative formulations on the horizon, now is the time to stay informed and proactive about your treatment choices
These supplements can enhance the effects of your GLP-1 diet by supporting overall health and improving bodily functions
The difference comes from tirzepatides dual GIP/GLP-1 mechanism versus semaglutides single GLP-1 action